DNA sequence variation associated with elevated fetal G gamma globin production

Area of Science:

• Molecular Genetics
• Hematology
• Human Genetics

Background:

• Fetal hemoglobin (Hb F) is crucial in conditions like sickle cell disease (SCD) and beta-thalassemia.
• Hb F composition, specifically the ratio of G gamma to A gamma chains, varies among individuals.
• Understanding the genetic regulation of G gamma chain production is vital for therapeutic strategies.

Purpose of the Study:

• To investigate the association between DNA sequence variation 5' to the G gamma gene and G gamma chain percentages in Hb F.
• To determine if a specific DNA polymorphism (T at position -158) influences G gamma chain production.

Main Methods:

• DNA analysis using restriction endonuclease Xmn I, which recognizes a specific sequence including position -158.
• Genotyping individuals from families with varying G gamma chain levels.
• Correlation of genotype with measured G gamma chain percentages in Hb F.

Main Results:

• Individuals with T at position -158 on both G gamma genes exhibited high G gamma values (mean 69.7%).
• Individuals with T at -158 on one G gamma gene showed intermediate G gamma values (mean 60.6%).
• Absence of T at -158 was generally associated with lower G gamma values (mean 39.6%).
• The T at -158 polymorphism is associated with a 3- to 11-fold increase in G gamma gene production.

Conclusions:

• The DNA sequence variation at position -158 5' of the G gamma gene is significantly associated with elevated G gamma chain production.
• This finding provides insight into the genetic factors controlling Hb F composition in hematological disorders.
• The T at -158 polymorphism contributes to increased G gamma globin, though to a lesser extent than other known regulatory elements.